Brief: Bonesupport Holding Upwardly Revises U.S. Market Opportunity
26/05/2026 06:34
May 26 (Reuters) - Bonesupport Holding AB BONEX.ST: HOSTS ITS CAPITAL MARKETS DAY UPWARD REVISION OF U.S. MARKET OPPORTUNITY TO ABOUT 460,000 PROCEDURES (FROM 380,000) PROGRESSION IN SPINE WITH MULTICENTRE STUDY, PLANNED TO START IN 2027 TARGETED FDA SUBMISSION NO LATER THAN 2031 Source text: ID:nMFNbZ12dZ Further company coverage: BONEX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))